- Report
- April 2023
- 145 Pages
United States
From €3054EUR$3,450USD£2,645GBP
- Report
- August 2021
- 119 Pages
Asia Pacific
From €3054EUR$3,450USD£2,645GBP
- Report
- September 2020
- 76 Pages
Global
From €3940EUR$4,450USD£3,412GBP
- Report
- June 2024
- 145 Pages
Global
From €2213EUR$2,500USD£1,917GBP
- Report
- June 2024
- 149 Pages
Global
From €2213EUR$2,500USD£1,917GBP
- Report
- June 2024
- 134 Pages
Global
From €2213EUR$2,500USD£1,917GBP
- Report
- May 2024
- 180 Pages
Global
From €2213EUR$2,500USD£1,917GBP
- Report
- January 2024
- 167 Pages
Global
From €2213EUR$2,500USD£1,917GBP
- Report
- January 2024
- 171 Pages
Global
From €2213EUR$2,500USD£1,917GBP
- Report
- October 2023
- 162 Pages
Global
From €2213EUR$2,500USD£1,917GBP
- Report
- February 2024
- 128 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- April 2023
- 114 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- April 2023
- 115 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- April 2023
- 120 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- April 2023
- 110 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- April 2023
- 115 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- April 2023
- 117 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- April 2023
- 117 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- August 2022
- 120 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- August 2022
- 115 Pages
Global
From €4205EUR$4,750USD£3,642GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more